nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—ABCC6—Dactinomycin—sarcoma	0.126	0.174	CbGbCtD
Indomethacin—ABCC6—Etoposide—sarcoma	0.0714	0.0979	CbGbCtD
Indomethacin—AKR1C3—Doxorubicin—sarcoma	0.0647	0.0888	CbGbCtD
Indomethacin—ABCC6—Doxorubicin—sarcoma	0.0487	0.0668	CbGbCtD
Indomethacin—UGT2B7—Epirubicin—sarcoma	0.038	0.0522	CbGbCtD
Indomethacin—ABCC3—Vincristine—sarcoma	0.0374	0.0513	CbGbCtD
Indomethacin—ABCC1—Dactinomycin—sarcoma	0.0373	0.0512	CbGbCtD
Indomethacin—ABCC3—Etoposide—sarcoma	0.0343	0.047	CbGbCtD
Indomethacin—ABCC1—Mitoxantrone—sarcoma	0.0334	0.0458	CbGbCtD
Indomethacin—ABCC1—Epirubicin—sarcoma	0.027	0.0371	CbGbCtD
Indomethacin—UGT1A1—Etoposide—sarcoma	0.0256	0.0351	CbGbCtD
Indomethacin—ABCC3—Doxorubicin—sarcoma	0.0234	0.0321	CbGbCtD
Indomethacin—ABCC1—Vincristine—sarcoma	0.023	0.0315	CbGbCtD
Indomethacin—ABCC1—Etoposide—sarcoma	0.021	0.0289	CbGbCtD
Indomethacin—ABCC2—Vincristine—sarcoma	0.017	0.0233	CbGbCtD
Indomethacin—ABCC2—Etoposide—sarcoma	0.0156	0.0214	CbGbCtD
Indomethacin—PTGS2—Etoposide—sarcoma	0.0154	0.0211	CbGbCtD
Indomethacin—ABCC1—Doxorubicin—sarcoma	0.0144	0.0197	CbGbCtD
Indomethacin—PTGS1—Etoposide—sarcoma	0.013	0.0178	CbGbCtD
Indomethacin—ABCC2—Doxorubicin—sarcoma	0.0106	0.0146	CbGbCtD
Indomethacin—ABCB1—Dactinomycin—sarcoma	0.009	0.0124	CbGbCtD
Indomethacin—ABCB1—Mitoxantrone—sarcoma	0.00805	0.0111	CbGbCtD
Indomethacin—ABCB1—Vincristine—sarcoma	0.00554	0.00761	CbGbCtD
Indomethacin—ABCC6—dermis—sarcoma	0.00522	0.0518	CbGeAlD
Indomethacin—ABCB1—Etoposide—sarcoma	0.00508	0.00697	CbGbCtD
Indomethacin—ABCB1—Doxorubicin—sarcoma	0.00346	0.00475	CbGbCtD
Indomethacin—CES1—larynx—sarcoma	0.00278	0.0275	CbGeAlD
Indomethacin—PPARG—dermis—sarcoma	0.00271	0.0269	CbGeAlD
Indomethacin—PPARG—periosteum—sarcoma	0.00224	0.0222	CbGeAlD
Indomethacin—ABCC11—mammary gland—sarcoma	0.00224	0.0222	CbGeAlD
Indomethacin—PTGDR2—hematopoietic system—sarcoma	0.00207	0.0206	CbGeAlD
Indomethacin—PPARG—leg—sarcoma	0.00179	0.0177	CbGeAlD
Indomethacin—PPARG—forelimb—sarcoma	0.00178	0.0176	CbGeAlD
Indomethacin—PTGR2—myometrium—sarcoma	0.0016	0.0159	CbGeAlD
Indomethacin—PPARG—hindlimb—sarcoma	0.0016	0.0158	CbGeAlD
Indomethacin—PTGR2—embryo—sarcoma	0.00154	0.0153	CbGeAlD
Indomethacin—ABCC11—embryo—sarcoma	0.00153	0.0151	CbGeAlD
Indomethacin—PTGR2—seminal vesicle—sarcoma	0.00145	0.0144	CbGeAlD
Indomethacin—GLO1—mammary gland—sarcoma	0.0014	0.0138	CbGeAlD
Indomethacin—ABCC6—Podofilox—Etoposide—sarcoma	0.00137	0.344	CbGdCrCtD
Indomethacin—PTGDR2—tendon—sarcoma	0.00137	0.0136	CbGeAlD
Indomethacin—PPARG—appendage—sarcoma	0.00137	0.0136	CbGeAlD
Indomethacin—AKR1C3—Podofilox—Etoposide—sarcoma	0.0012	0.301	CbGdCrCtD
Indomethacin—PTGS2—periosteum—sarcoma	0.00115	0.0114	CbGeAlD
Indomethacin—PTGR2—cardiac atrium—sarcoma	0.00105	0.0104	CbGeAlD
Indomethacin—GLO1—myometrium—sarcoma	0.000991	0.00982	CbGeAlD
Indomethacin—PLA2G2A—myometrium—sarcoma	0.000921	0.00913	CbGeAlD
Indomethacin—PTGS2—leg—sarcoma	0.000914	0.00906	CbGeAlD
Indomethacin—CXCL8—myometrium—sarcoma	0.000912	0.00904	CbGeAlD
Indomethacin—PTGR2—tendon—sarcoma	0.000911	0.00903	CbGeAlD
Indomethacin—GLO1—seminal vesicle—sarcoma	0.000895	0.00887	CbGeAlD
Indomethacin—GLO1—hematopoietic system—sarcoma	0.000851	0.00843	CbGeAlD
Indomethacin—PLA2G2A—seminal vesicle—sarcoma	0.000832	0.00825	CbGeAlD
Indomethacin—PPARA—embryo—sarcoma	0.000828	0.0082	CbGeAlD
Indomethacin—PPARG—endothelium—sarcoma	0.000827	0.0082	CbGeAlD
Indomethacin—AKR1C3—Vinblastine—Vincristine—sarcoma	0.000827	0.207	CbGdCrCtD
Indomethacin—PTGS2—hindlimb—sarcoma	0.000816	0.00809	CbGeAlD
Indomethacin—PTGS2—cartilage tissue—sarcoma	0.000804	0.00796	CbGeAlD
Indomethacin—PLA2G2A—hematopoietic system—sarcoma	0.000791	0.00784	CbGeAlD
Indomethacin—ABCC6—hematopoietic system—sarcoma	0.000783	0.00776	CbGeAlD
Indomethacin—SLCO1B1—mammary gland—sarcoma	0.000773	0.00766	CbGeAlD
Indomethacin—PLA2G2A—connective tissue—sarcoma	0.000762	0.00755	CbGeAlD
Indomethacin—PTGR2—testis—sarcoma	0.000755	0.00748	CbGeAlD
Indomethacin—ABCC6—connective tissue—sarcoma	0.000754	0.00747	CbGeAlD
Indomethacin—GLO1—smooth muscle tissue—sarcoma	0.000749	0.00743	CbGeAlD
Indomethacin—SLC10A1—seminal vesicle—sarcoma	0.000747	0.00741	CbGeAlD
Indomethacin—ABCC11—testis—sarcoma	0.000747	0.0074	CbGeAlD
Indomethacin—GLO1—skin of body—sarcoma	0.00074	0.00733	CbGeAlD
Indomethacin—PPARA—hematopoietic system—sarcoma	0.000739	0.00732	CbGeAlD
Indomethacin—AKR1C3—myometrium—sarcoma	0.000715	0.00709	CbGeAlD
Indomethacin—PTGR2—liver—sarcoma	0.000713	0.00707	CbGeAlD
Indomethacin—PPARA—connective tissue—sarcoma	0.000711	0.00705	CbGeAlD
Indomethacin—ABCC11—liver—sarcoma	0.000706	0.007	CbGeAlD
Indomethacin—PTGS2—appendage—sarcoma	0.0007	0.00694	CbGeAlD
Indomethacin—PLA2G2A—smooth muscle tissue—sarcoma	0.000697	0.0069	CbGeAlD
Indomethacin—CXCL8—smooth muscle tissue—sarcoma	0.00069	0.00684	CbGeAlD
Indomethacin—PPARG—mammary gland—sarcoma	0.000667	0.00661	CbGeAlD
Indomethacin—PPARA—smooth muscle tissue—sarcoma	0.000651	0.00645	CbGeAlD
Indomethacin—GLO1—cardiac atrium—sarcoma	0.000646	0.0064	CbGeAlD
Indomethacin—AKR1C3—seminal vesicle—sarcoma	0.000646	0.0064	CbGeAlD
Indomethacin—GLO1—uterus—sarcoma	0.000643	0.00637	CbGeAlD
Indomethacin—PPARA—skin of body—sarcoma	0.000642	0.00637	CbGeAlD
Indomethacin—ALB—mammary gland—sarcoma	0.000625	0.0062	CbGeAlD
Indomethacin—PLA2G2A—cardiac atrium—sarcoma	0.000601	0.00595	CbGeAlD
Indomethacin—GLO1—lymphoid tissue—sarcoma	0.000599	0.00594	CbGeAlD
Indomethacin—PPARG—Teniposide—Etoposide—sarcoma	0.000591	0.148	CbGdCrCtD
Indomethacin—UGT1A1—hematopoietic system—sarcoma	0.000566	0.00561	CbGeAlD
Indomethacin—GLO1—tendon—sarcoma	0.000563	0.00558	CbGeAlD
Indomethacin—PLA2G2A—lymphoid tissue—sarcoma	0.000557	0.00552	CbGeAlD
Indomethacin—CES1—hematopoietic system—sarcoma	0.000548	0.00543	CbGeAlD
Indomethacin—PTGR2—lymph node—sarcoma	0.000547	0.00542	CbGeAlD
Indomethacin—GLO1—bone marrow—sarcoma	0.000545	0.00541	CbGeAlD
Indomethacin—AKR1C3—smooth muscle tissue—sarcoma	0.000541	0.00536	CbGeAlD
Indomethacin—CES1—connective tissue—sarcoma	0.000528	0.00523	CbGeAlD
Indomethacin—PLA2G2A—tendon—sarcoma	0.000523	0.00519	CbGeAlD
Indomethacin—PPARA—lymphoid tissue—sarcoma	0.00052	0.00516	CbGeAlD
Indomethacin—CXCL8—bone marrow—sarcoma	0.000502	0.00497	CbGeAlD
Indomethacin—SLCO1B1—hematopoietic system—sarcoma	0.000471	0.00467	CbGeAlD
Indomethacin—GLO1—testis—sarcoma	0.000466	0.00462	CbGeAlD
Indomethacin—AKR1C3—cardiac atrium—sarcoma	0.000466	0.00462	CbGeAlD
Indomethacin—AKR1C3—uterus—sarcoma	0.000464	0.0046	CbGeAlD
Indomethacin—PPARG—embryo—sarcoma	0.000455	0.00451	CbGeAlD
Indomethacin—ABCC3—hematopoietic system—sarcoma	0.000447	0.00443	CbGeAlD
Indomethacin—PTGS1—endothelium—sarcoma	0.000442	0.00438	CbGeAlD
Indomethacin—GLO1—liver—sarcoma	0.000441	0.00437	CbGeAlD
Indomethacin—PLA2G2A—testis—sarcoma	0.000433	0.0043	CbGeAlD
Indomethacin—CXCL8—testis—sarcoma	0.000429	0.00425	CbGeAlD
Indomethacin—UGT1A9—liver—sarcoma	0.000428	0.00424	CbGeAlD
Indomethacin—PTGS2—endothelium—sarcoma	0.000423	0.00419	CbGeAlD
Indomethacin—PLA2G2A—liver—sarcoma	0.00041	0.00406	CbGeAlD
Indomethacin—PPARG—hematopoietic system—sarcoma	0.000406	0.00403	CbGeAlD
Indomethacin—AKR1C3—tendon—sarcoma	0.000406	0.00403	CbGeAlD
Indomethacin—ABCC6—liver—sarcoma	0.000406	0.00402	CbGeAlD
Indomethacin—CXCL8—liver—sarcoma	0.000406	0.00402	CbGeAlD
Indomethacin—PPARA—testis—sarcoma	0.000405	0.00401	CbGeAlD
Indomethacin—AKR1C3—bone marrow—sarcoma	0.000393	0.0039	CbGeAlD
Indomethacin—PPARG—connective tissue—sarcoma	0.000391	0.00388	CbGeAlD
Indomethacin—CYP2C9—mammary gland—sarcoma	0.00039	0.00387	CbGeAlD
Indomethacin—SLC10A1—testis—sarcoma	0.000389	0.00386	CbGeAlD
Indomethacin—CES1—lymphoid tissue—sarcoma	0.000386	0.00383	CbGeAlD
Indomethacin—SLCO1A2—hematopoietic system—sarcoma	0.000383	0.0038	CbGeAlD
Indomethacin—PPARA—liver—sarcoma	0.000383	0.00379	CbGeAlD
Indomethacin—ABCC4—hematopoietic system—sarcoma	0.000369	0.00366	CbGeAlD
Indomethacin—SLC10A1—liver—sarcoma	0.000368	0.00365	CbGeAlD
Indomethacin—ABCC1—myometrium—sarcoma	0.000366	0.00363	CbGeAlD
Indomethacin—SLC22A8—hematopoietic system—sarcoma	0.000366	0.00363	CbGeAlD
Indomethacin—UGT2B7—testis—sarcoma	0.000365	0.00362	CbGeAlD
Indomethacin—PPARG—smooth muscle tissue—sarcoma	0.000358	0.00355	CbGeAlD
Indomethacin—PPARG—skin of body—sarcoma	0.000353	0.0035	CbGeAlD
Indomethacin—SLC22A7—testis—sarcoma	0.000347	0.00344	CbGeAlD
Indomethacin—UGT2B7—liver—sarcoma	0.000345	0.00342	CbGeAlD
Indomethacin—GLO1—lymph node—sarcoma	0.000338	0.00335	CbGeAlD
Indomethacin—AKR1C3—testis—sarcoma	0.000336	0.00333	CbGeAlD
Indomethacin—SLC22A11—liver—sarcoma	0.000336	0.00333	CbGeAlD
Indomethacin—ABCC1—seminal vesicle—sarcoma	0.000331	0.00328	CbGeAlD
Indomethacin—SLC22A7—liver—sarcoma	0.000328	0.00325	CbGeAlD
Indomethacin—AKR1C3—liver—sarcoma	0.000318	0.00315	CbGeAlD
Indomethacin—PLA2G2A—lymph node—sarcoma	0.000314	0.00311	CbGeAlD
Indomethacin—CXCL8—lymph node—sarcoma	0.000311	0.00308	CbGeAlD
Indomethacin—PPARG—uterus—sarcoma	0.000307	0.00304	CbGeAlD
Indomethacin—CYP2C19—hematopoietic system—sarcoma	0.000307	0.00304	CbGeAlD
Indomethacin—CES1—testis—sarcoma	0.0003	0.00298	CbGeAlD
Indomethacin—PPARA—lymph node—sarcoma	0.000293	0.00291	CbGeAlD
Indomethacin—UGT1A1—liver—sarcoma	0.000293	0.00291	CbGeAlD
Indomethacin—PPARG—lymphoid tissue—sarcoma	0.000286	0.00283	CbGeAlD
Indomethacin—CES1—liver—sarcoma	0.000284	0.00282	CbGeAlD
Indomethacin—ABCC4—uterus—sarcoma	0.000279	0.00276	CbGeAlD
Indomethacin—PPARG—tendon—sarcoma	0.000269	0.00266	CbGeAlD
Indomethacin—PPARG—bone marrow—sarcoma	0.00026	0.00258	CbGeAlD
Indomethacin—ABCC3—testis—sarcoma	0.000245	0.00243	CbGeAlD
Indomethacin—ABCC4—tendon—sarcoma	0.000244	0.00242	CbGeAlD
Indomethacin—SLCO1B1—liver—sarcoma	0.000244	0.00242	CbGeAlD
Indomethacin—AKR1C3—lymph node—sarcoma	0.000244	0.00242	CbGeAlD
Indomethacin—PTGS2—myometrium—sarcoma	0.000242	0.0024	CbGeAlD
Indomethacin—ABCC1—cardiac atrium—sarcoma	0.000239	0.00237	CbGeAlD
Indomethacin—CYP2C9—hematopoietic system—sarcoma	0.000238	0.00236	CbGeAlD
Indomethacin—ABCC1—uterus—sarcoma	0.000238	0.00235	CbGeAlD
Indomethacin—ABCC4—bone marrow—sarcoma	0.000236	0.00234	CbGeAlD
Indomethacin—ABCC2—tendon—sarcoma	0.000236	0.00234	CbGeAlD
Indomethacin—PTGS2—embryo—sarcoma	0.000233	0.0023	CbGeAlD
Indomethacin—ABCC3—liver—sarcoma	0.000232	0.00229	CbGeAlD
Indomethacin—PTGS1—seminal vesicle—sarcoma	0.000229	0.00226	CbGeAlD
Indomethacin—PPARG—testis—sarcoma	0.000223	0.00221	CbGeAlD
Indomethacin—PTGS2—seminal vesicle—sarcoma	0.000218	0.00216	CbGeAlD
Indomethacin—CES1—lymph node—sarcoma	0.000218	0.00216	CbGeAlD
Indomethacin—PTGS1—hematopoietic system—sarcoma	0.000217	0.00215	CbGeAlD
Indomethacin—PPARG—liver—sarcoma	0.00021	0.00209	CbGeAlD
Indomethacin—SLCO1A2—testis—sarcoma	0.00021	0.00208	CbGeAlD
Indomethacin—PTGS1—connective tissue—sarcoma	0.000209	0.00207	CbGeAlD
Indomethacin—ALB—testis—sarcoma	0.000209	0.00207	CbGeAlD
Indomethacin—ABCC1—tendon—sarcoma	0.000208	0.00206	CbGeAlD
Indomethacin—PTGS2—hematopoietic system—sarcoma	0.000208	0.00206	CbGeAlD
Indomethacin—ABCC4—testis—sarcoma	0.000202	0.002	CbGeAlD
Indomethacin—PTGS2—connective tissue—sarcoma	0.0002	0.00198	CbGeAlD
Indomethacin—SLCO1A2—liver—sarcoma	0.000199	0.00197	CbGeAlD
Indomethacin—ALB—liver—sarcoma	0.000197	0.00196	CbGeAlD
Indomethacin—ABCC2—testis—sarcoma	0.000196	0.00194	CbGeAlD
Indomethacin—PTGS1—smooth muscle tissue—sarcoma	0.000191	0.0019	CbGeAlD
Indomethacin—ABCC4—liver—sarcoma	0.000191	0.00189	CbGeAlD
Indomethacin—PTGS1—skin of body—sarcoma	0.000189	0.00187	CbGeAlD
Indomethacin—ABCC2—liver—sarcoma	0.000185	0.00183	CbGeAlD
Indomethacin—PTGS2—smooth muscle tissue—sarcoma	0.000183	0.00181	CbGeAlD
Indomethacin—PTGS2—skin of body—sarcoma	0.00018	0.00179	CbGeAlD
Indomethacin—ABCC3—lymph node—sarcoma	0.000178	0.00176	CbGeAlD
Indomethacin—ABCC1—testis—sarcoma	0.000172	0.00171	CbGeAlD
Indomethacin—Loss of consciousness—Etoposide—sarcoma	0.000166	0.00133	CcSEcCtD
Indomethacin—Decreased appetite—Vincristine—sarcoma	0.000165	0.00133	CcSEcCtD
Indomethacin—Dyspnoea—Mitoxantrone—sarcoma	0.000165	0.00133	CcSEcCtD
Indomethacin—PTGS1—cardiac atrium—sarcoma	0.000165	0.00163	CbGeAlD
Indomethacin—Somnolence—Mitoxantrone—sarcoma	0.000165	0.00132	CcSEcCtD
Indomethacin—PTGS1—uterus—sarcoma	0.000164	0.00163	CbGeAlD
Indomethacin—Fatigue—Vincristine—sarcoma	0.000164	0.00132	CcSEcCtD
Indomethacin—Convulsion—Etoposide—sarcoma	0.000164	0.00131	CcSEcCtD
Indomethacin—Hyponatraemia—Doxorubicin—sarcoma	0.000163	0.00131	CcSEcCtD
Indomethacin—Dyspepsia—Mitoxantrone—sarcoma	0.000163	0.00131	CcSEcCtD
Indomethacin—Hypertension—Etoposide—sarcoma	0.000163	0.00131	CcSEcCtD
Indomethacin—ABCC1—liver—sarcoma	0.000163	0.00162	CbGeAlD
Indomethacin—Constipation—Vincristine—sarcoma	0.000163	0.00131	CcSEcCtD
Indomethacin—Pain—Vincristine—sarcoma	0.000163	0.00131	CcSEcCtD
Indomethacin—Diplopia—Doxorubicin—sarcoma	0.000163	0.00131	CcSEcCtD
Indomethacin—Osteoarthritis—Doxorubicin—sarcoma	0.000163	0.00131	CcSEcCtD
Indomethacin—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000163	0.00131	CcSEcCtD
Indomethacin—PPARG—lymph node—sarcoma	0.000161	0.0016	CbGeAlD
Indomethacin—Decreased appetite—Mitoxantrone—sarcoma	0.000161	0.00129	CcSEcCtD
Indomethacin—Chest pain—Etoposide—sarcoma	0.000161	0.00129	CcSEcCtD
Indomethacin—Abdominal pain upper—Epirubicin—sarcoma	0.000161	0.00129	CcSEcCtD
Indomethacin—Fatigue—Mitoxantrone—sarcoma	0.00016	0.00128	CcSEcCtD
Indomethacin—CYP2C19—liver—sarcoma	0.000159	0.00158	CbGeAlD
Indomethacin—Discomfort—Etoposide—sarcoma	0.000159	0.00128	CcSEcCtD
Indomethacin—Pain—Mitoxantrone—sarcoma	0.000158	0.00127	CcSEcCtD
Indomethacin—Constipation—Mitoxantrone—sarcoma	0.000158	0.00127	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000158	0.00127	CcSEcCtD
Indomethacin—Hypersensitivity—Thiotepa—sarcoma	0.000158	0.00127	CcSEcCtD
Indomethacin—Hypersensitivity—Dactinomycin—sarcoma	0.000157	0.00126	CcSEcCtD
Indomethacin—PTGS2—uterus—sarcoma	0.000157	0.00155	CbGeAlD
Indomethacin—Gastrointestinal pain—Vincristine—sarcoma	0.000156	0.00125	CcSEcCtD
Indomethacin—Gastritis—Epirubicin—sarcoma	0.000156	0.00125	CcSEcCtD
Indomethacin—Confusional state—Etoposide—sarcoma	0.000155	0.00125	CcSEcCtD
Indomethacin—Muscular weakness—Epirubicin—sarcoma	0.000155	0.00124	CcSEcCtD
Indomethacin—Anaphylactic shock—Etoposide—sarcoma	0.000154	0.00124	CcSEcCtD
Indomethacin—Asthenia—Thiotepa—sarcoma	0.000154	0.00124	CcSEcCtD
Indomethacin—Abdominal distension—Epirubicin—sarcoma	0.000153	0.00123	CcSEcCtD
Indomethacin—Asthenia—Dactinomycin—sarcoma	0.000153	0.00123	CcSEcCtD
Indomethacin—Feeling abnormal—Mitoxantrone—sarcoma	0.000153	0.00123	CcSEcCtD
Indomethacin—Asthma—Epirubicin—sarcoma	0.000152	0.00122	CcSEcCtD
Indomethacin—Pruritus—Thiotepa—sarcoma	0.000152	0.00122	CcSEcCtD
Indomethacin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000152	0.00122	CcSEcCtD
Indomethacin—ALB—lymph node—sarcoma	0.000151	0.0015	CbGeAlD
Indomethacin—Thrombocytopenia—Etoposide—sarcoma	0.000151	0.00121	CcSEcCtD
Indomethacin—Tachycardia—Etoposide—sarcoma	0.00015	0.00121	CcSEcCtD
Indomethacin—Body temperature increased—Vincristine—sarcoma	0.00015	0.00121	CcSEcCtD
Indomethacin—Abdominal pain—Vincristine—sarcoma	0.00015	0.00121	CcSEcCtD
Indomethacin—ABCB1—myometrium—sarcoma	0.00015	0.00148	CbGeAlD
Indomethacin—Hyperhidrosis—Etoposide—sarcoma	0.000149	0.0012	CcSEcCtD
Indomethacin—Abdominal pain upper—Doxorubicin—sarcoma	0.000149	0.00119	CcSEcCtD
Indomethacin—Urticaria—Mitoxantrone—sarcoma	0.000147	0.00118	CcSEcCtD
Indomethacin—Anorexia—Etoposide—sarcoma	0.000147	0.00118	CcSEcCtD
Indomethacin—Diarrhoea—Thiotepa—sarcoma	0.000147	0.00118	CcSEcCtD
Indomethacin—ABCC4—lymph node—sarcoma	0.000147	0.00145	CbGeAlD
Indomethacin—Body temperature increased—Mitoxantrone—sarcoma	0.000146	0.00118	CcSEcCtD
Indomethacin—Abdominal pain—Mitoxantrone—sarcoma	0.000146	0.00118	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000146	0.00118	CcSEcCtD
Indomethacin—PTGS2—lymphoid tissue—sarcoma	0.000146	0.00145	CbGeAlD
Indomethacin—Diarrhoea—Dactinomycin—sarcoma	0.000146	0.00117	CcSEcCtD
Indomethacin—Pancytopenia—Epirubicin—sarcoma	0.000144	0.00116	CcSEcCtD
Indomethacin—Hypotension—Etoposide—sarcoma	0.000144	0.00116	CcSEcCtD
Indomethacin—Gastritis—Doxorubicin—sarcoma	0.000144	0.00116	CcSEcCtD
Indomethacin—ABCB1—embryo—sarcoma	0.000144	0.00143	CbGeAlD
Indomethacin—PTGS1—tendon—sarcoma	0.000144	0.00142	CbGeAlD
Indomethacin—Muscular weakness—Doxorubicin—sarcoma	0.000143	0.00115	CcSEcCtD
Indomethacin—Dizziness—Thiotepa—sarcoma	0.000142	0.00114	CcSEcCtD
Indomethacin—ABCC2—lymph node—sarcoma	0.000142	0.00141	CbGeAlD
Indomethacin—Abdominal distension—Doxorubicin—sarcoma	0.000142	0.00114	CcSEcCtD
Indomethacin—Asthma—Doxorubicin—sarcoma	0.000141	0.00113	CcSEcCtD
Indomethacin—Pollakiuria—Epirubicin—sarcoma	0.00014	0.00113	CcSEcCtD
Indomethacin—Hypersensitivity—Vincristine—sarcoma	0.00014	0.00113	CcSEcCtD
Indomethacin—Paraesthesia—Etoposide—sarcoma	0.000138	0.00111	CcSEcCtD
Indomethacin—Weight increased—Epirubicin—sarcoma	0.000138	0.00111	CcSEcCtD
Indomethacin—Dyspnoea—Etoposide—sarcoma	0.000137	0.0011	CcSEcCtD
Indomethacin—PTGS2—tendon—sarcoma	0.000137	0.00136	CbGeAlD
Indomethacin—Hyperglycaemia—Epirubicin—sarcoma	0.000137	0.0011	CcSEcCtD
Indomethacin—Somnolence—Etoposide—sarcoma	0.000137	0.0011	CcSEcCtD
Indomethacin—Hypersensitivity—Mitoxantrone—sarcoma	0.000137	0.0011	CcSEcCtD
Indomethacin—Asthenia—Vincristine—sarcoma	0.000137	0.0011	CcSEcCtD
Indomethacin—Vomiting—Thiotepa—sarcoma	0.000136	0.0011	CcSEcCtD
Indomethacin—Drowsiness—Epirubicin—sarcoma	0.000135	0.00109	CcSEcCtD
Indomethacin—Vomiting—Dactinomycin—sarcoma	0.000135	0.00109	CcSEcCtD
Indomethacin—Rash—Thiotepa—sarcoma	0.000135	0.00109	CcSEcCtD
Indomethacin—Dermatitis—Thiotepa—sarcoma	0.000135	0.00109	CcSEcCtD
Indomethacin—ABCB1—seminal vesicle—sarcoma	0.000135	0.00134	CbGeAlD
Indomethacin—Headache—Thiotepa—sarcoma	0.000134	0.00108	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000134	0.00108	CcSEcCtD
Indomethacin—Rash—Dactinomycin—sarcoma	0.000134	0.00108	CcSEcCtD
Indomethacin—Decreased appetite—Etoposide—sarcoma	0.000134	0.00108	CcSEcCtD
Indomethacin—Pancytopenia—Doxorubicin—sarcoma	0.000134	0.00107	CcSEcCtD
Indomethacin—Renal failure—Epirubicin—sarcoma	0.000133	0.00107	CcSEcCtD
Indomethacin—PTGS2—bone marrow—sarcoma	0.000133	0.00132	CbGeAlD
Indomethacin—Asthenia—Mitoxantrone—sarcoma	0.000133	0.00107	CcSEcCtD
Indomethacin—Fatigue—Etoposide—sarcoma	0.000133	0.00107	CcSEcCtD
Indomethacin—Neuropathy peripheral—Epirubicin—sarcoma	0.000133	0.00107	CcSEcCtD
Indomethacin—Jaundice—Epirubicin—sarcoma	0.000132	0.00106	CcSEcCtD
Indomethacin—Stomatitis—Epirubicin—sarcoma	0.000132	0.00106	CcSEcCtD
Indomethacin—Constipation—Etoposide—sarcoma	0.000132	0.00106	CcSEcCtD
Indomethacin—Pain—Etoposide—sarcoma	0.000132	0.00106	CcSEcCtD
Indomethacin—Diarrhoea—Vincristine—sarcoma	0.00013	0.00105	CcSEcCtD
Indomethacin—Sweating—Epirubicin—sarcoma	0.00013	0.00104	CcSEcCtD
Indomethacin—Pollakiuria—Doxorubicin—sarcoma	0.00013	0.00104	CcSEcCtD
Indomethacin—Haematuria—Epirubicin—sarcoma	0.000129	0.00104	CcSEcCtD
Indomethacin—ABCB1—hematopoietic system—sarcoma	0.000128	0.00127	CbGeAlD
Indomethacin—Weight increased—Doxorubicin—sarcoma	0.000128	0.00103	CcSEcCtD
Indomethacin—Epistaxis—Epirubicin—sarcoma	0.000128	0.00103	CcSEcCtD
Indomethacin—Nausea—Thiotepa—sarcoma	0.000127	0.00102	CcSEcCtD
Indomethacin—Feeling abnormal—Etoposide—sarcoma	0.000127	0.00102	CcSEcCtD
Indomethacin—Hyperglycaemia—Doxorubicin—sarcoma	0.000127	0.00102	CcSEcCtD
Indomethacin—Diarrhoea—Mitoxantrone—sarcoma	0.000127	0.00102	CcSEcCtD
Indomethacin—Nausea—Dactinomycin—sarcoma	0.000127	0.00102	CcSEcCtD
Indomethacin—Agranulocytosis—Epirubicin—sarcoma	0.000126	0.00101	CcSEcCtD
Indomethacin—Gastrointestinal pain—Etoposide—sarcoma	0.000126	0.00101	CcSEcCtD
Indomethacin—Dizziness—Vincristine—sarcoma	0.000126	0.00101	CcSEcCtD
Indomethacin—Drowsiness—Doxorubicin—sarcoma	0.000125	0.00101	CcSEcCtD
Indomethacin—ABCC1—lymph node—sarcoma	0.000125	0.00124	CbGeAlD
Indomethacin—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000124	0.000998	CcSEcCtD
Indomethacin—Bradycardia—Epirubicin—sarcoma	0.000124	0.000994	CcSEcCtD
Indomethacin—CYP2C9—liver—sarcoma	0.000123	0.00122	CbGeAlD
Indomethacin—Renal failure—Doxorubicin—sarcoma	0.000123	0.000989	CcSEcCtD
Indomethacin—Neuropathy peripheral—Doxorubicin—sarcoma	0.000123	0.000986	CcSEcCtD
Indomethacin—Urticaria—Etoposide—sarcoma	0.000122	0.000983	CcSEcCtD
Indomethacin—Haemoglobin—Epirubicin—sarcoma	0.000122	0.000981	CcSEcCtD
Indomethacin—Jaundice—Doxorubicin—sarcoma	0.000122	0.000981	CcSEcCtD
Indomethacin—Stomatitis—Doxorubicin—sarcoma	0.000122	0.000981	CcSEcCtD
Indomethacin—Body temperature increased—Etoposide—sarcoma	0.000122	0.000978	CcSEcCtD
Indomethacin—Abdominal pain—Etoposide—sarcoma	0.000122	0.000978	CcSEcCtD
Indomethacin—Hepatitis—Epirubicin—sarcoma	0.000122	0.000976	CcSEcCtD
Indomethacin—Haemorrhage—Epirubicin—sarcoma	0.000122	0.000976	CcSEcCtD
Indomethacin—Vomiting—Vincristine—sarcoma	0.000121	0.000971	CcSEcCtD
Indomethacin—Sweating—Doxorubicin—sarcoma	0.00012	0.000965	CcSEcCtD
Indomethacin—Rash—Vincristine—sarcoma	0.00012	0.000963	CcSEcCtD
Indomethacin—Dermatitis—Vincristine—sarcoma	0.00012	0.000962	CcSEcCtD
Indomethacin—Haematuria—Doxorubicin—sarcoma	0.00012	0.000959	CcSEcCtD
Indomethacin—Headache—Vincristine—sarcoma	0.000119	0.000957	CcSEcCtD
Indomethacin—PTGS1—testis—sarcoma	0.000119	0.00118	CbGeAlD
Indomethacin—Epistaxis—Doxorubicin—sarcoma	0.000118	0.000949	CcSEcCtD
Indomethacin—Vomiting—Mitoxantrone—sarcoma	0.000118	0.000946	CcSEcCtD
Indomethacin—Agranulocytosis—Doxorubicin—sarcoma	0.000117	0.000939	CcSEcCtD
Indomethacin—Rash—Mitoxantrone—sarcoma	0.000117	0.000938	CcSEcCtD
Indomethacin—Dermatitis—Mitoxantrone—sarcoma	0.000117	0.000937	CcSEcCtD
Indomethacin—Headache—Mitoxantrone—sarcoma	0.000116	0.000932	CcSEcCtD
Indomethacin—Erythema multiforme—Epirubicin—sarcoma	0.000115	0.000923	CcSEcCtD
Indomethacin—Bradycardia—Doxorubicin—sarcoma	0.000115	0.00092	CcSEcCtD
Indomethacin—Hypersensitivity—Etoposide—sarcoma	0.000114	0.000912	CcSEcCtD
Indomethacin—Tinnitus—Epirubicin—sarcoma	0.000113	0.00091	CcSEcCtD
Indomethacin—Haemoglobin—Doxorubicin—sarcoma	0.000113	0.000908	CcSEcCtD
Indomethacin—Nausea—Vincristine—sarcoma	0.000113	0.000907	CcSEcCtD
Indomethacin—Flushing—Epirubicin—sarcoma	0.000113	0.000906	CcSEcCtD
Indomethacin—Haemorrhage—Doxorubicin—sarcoma	0.000113	0.000903	CcSEcCtD
Indomethacin—Hepatitis—Doxorubicin—sarcoma	0.000113	0.000903	CcSEcCtD
Indomethacin—Asthenia—Etoposide—sarcoma	0.000111	0.000888	CcSEcCtD
Indomethacin—Nausea—Mitoxantrone—sarcoma	0.00011	0.000884	CcSEcCtD
Indomethacin—Pruritus—Etoposide—sarcoma	0.000109	0.000875	CcSEcCtD
Indomethacin—Arrhythmia—Epirubicin—sarcoma	0.000109	0.000872	CcSEcCtD
Indomethacin—PTGS2—liver—sarcoma	0.000108	0.00107	CbGeAlD
Indomethacin—Alopecia—Epirubicin—sarcoma	0.000107	0.000863	CcSEcCtD
Indomethacin—Erythema multiforme—Doxorubicin—sarcoma	0.000106	0.000854	CcSEcCtD
Indomethacin—Erythema—Epirubicin—sarcoma	0.000106	0.00085	CcSEcCtD
Indomethacin—Diarrhoea—Etoposide—sarcoma	0.000105	0.000847	CcSEcCtD
Indomethacin—Tinnitus—Doxorubicin—sarcoma	0.000105	0.000842	CcSEcCtD
Indomethacin—Flushing—Doxorubicin—sarcoma	0.000104	0.000838	CcSEcCtD
Indomethacin—Flatulence—Epirubicin—sarcoma	0.000104	0.000837	CcSEcCtD
Indomethacin—Tension—Epirubicin—sarcoma	0.000104	0.000834	CcSEcCtD
Indomethacin—Nervousness—Epirubicin—sarcoma	0.000103	0.000825	CcSEcCtD
Indomethacin—Dizziness—Etoposide—sarcoma	0.000102	0.000818	CcSEcCtD
Indomethacin—Arrhythmia—Doxorubicin—sarcoma	0.000101	0.000807	CcSEcCtD
Indomethacin—Vision blurred—Epirubicin—sarcoma	9.98e-05	0.000801	CcSEcCtD
Indomethacin—Alopecia—Doxorubicin—sarcoma	9.94e-05	0.000798	CcSEcCtD
Indomethacin—Ill-defined disorder—Epirubicin—sarcoma	9.82e-05	0.000789	CcSEcCtD
Indomethacin—Vomiting—Etoposide—sarcoma	9.8e-05	0.000787	CcSEcCtD
Indomethacin—Erythema—Doxorubicin—sarcoma	9.8e-05	0.000786	CcSEcCtD
Indomethacin—Anaemia—Epirubicin—sarcoma	9.78e-05	0.000786	CcSEcCtD
Indomethacin—Rash—Etoposide—sarcoma	9.72e-05	0.00078	CcSEcCtD
Indomethacin—Dermatitis—Etoposide—sarcoma	9.71e-05	0.000779	CcSEcCtD
Indomethacin—ABCB1—uterus—sarcoma	9.7e-05	0.000961	CbGeAlD
Indomethacin—Headache—Etoposide—sarcoma	9.66e-05	0.000775	CcSEcCtD
Indomethacin—Flatulence—Doxorubicin—sarcoma	9.65e-05	0.000775	CcSEcCtD
Indomethacin—Tension—Doxorubicin—sarcoma	9.61e-05	0.000772	CcSEcCtD
Indomethacin—Malaise—Epirubicin—sarcoma	9.55e-05	0.000766	CcSEcCtD
Indomethacin—Nervousness—Doxorubicin—sarcoma	9.51e-05	0.000764	CcSEcCtD
Indomethacin—Vertigo—Epirubicin—sarcoma	9.51e-05	0.000764	CcSEcCtD
Indomethacin—Syncope—Epirubicin—sarcoma	9.49e-05	0.000762	CcSEcCtD
Indomethacin—Leukopenia—Epirubicin—sarcoma	9.48e-05	0.000761	CcSEcCtD
Indomethacin—Palpitations—Epirubicin—sarcoma	9.36e-05	0.000751	CcSEcCtD
Indomethacin—Loss of consciousness—Epirubicin—sarcoma	9.3e-05	0.000747	CcSEcCtD
Indomethacin—Vision blurred—Doxorubicin—sarcoma	9.23e-05	0.000741	CcSEcCtD
Indomethacin—Convulsion—Epirubicin—sarcoma	9.17e-05	0.000736	CcSEcCtD
Indomethacin—Nausea—Etoposide—sarcoma	9.16e-05	0.000735	CcSEcCtD
Indomethacin—Hypertension—Epirubicin—sarcoma	9.14e-05	0.000734	CcSEcCtD
Indomethacin—Ill-defined disorder—Doxorubicin—sarcoma	9.09e-05	0.00073	CcSEcCtD
Indomethacin—Anaemia—Doxorubicin—sarcoma	9.05e-05	0.000727	CcSEcCtD
Indomethacin—ABCB1—lymphoid tissue—sarcoma	9.04e-05	0.000896	CbGeAlD
Indomethacin—Chest pain—Epirubicin—sarcoma	9.01e-05	0.000724	CcSEcCtD
Indomethacin—Anxiety—Epirubicin—sarcoma	8.98e-05	0.000721	CcSEcCtD
Indomethacin—Discomfort—Epirubicin—sarcoma	8.91e-05	0.000715	CcSEcCtD
Indomethacin—Malaise—Doxorubicin—sarcoma	8.83e-05	0.000709	CcSEcCtD
Indomethacin—Vertigo—Doxorubicin—sarcoma	8.8e-05	0.000707	CcSEcCtD
Indomethacin—Syncope—Doxorubicin—sarcoma	8.78e-05	0.000705	CcSEcCtD
Indomethacin—Leukopenia—Doxorubicin—sarcoma	8.77e-05	0.000704	CcSEcCtD
Indomethacin—Confusional state—Epirubicin—sarcoma	8.71e-05	0.000699	CcSEcCtD
Indomethacin—Palpitations—Doxorubicin—sarcoma	8.66e-05	0.000695	CcSEcCtD
Indomethacin—Oedema—Epirubicin—sarcoma	8.64e-05	0.000694	CcSEcCtD
Indomethacin—Anaphylactic shock—Epirubicin—sarcoma	8.64e-05	0.000694	CcSEcCtD
Indomethacin—PTGS1—lymph node—sarcoma	8.63e-05	0.000855	CbGeAlD
Indomethacin—Loss of consciousness—Doxorubicin—sarcoma	8.61e-05	0.000691	CcSEcCtD
Indomethacin—Shock—Epirubicin—sarcoma	8.5e-05	0.000682	CcSEcCtD
Indomethacin—Convulsion—Doxorubicin—sarcoma	8.49e-05	0.000681	CcSEcCtD
Indomethacin—Thrombocytopenia—Epirubicin—sarcoma	8.46e-05	0.000679	CcSEcCtD
Indomethacin—Hypertension—Doxorubicin—sarcoma	8.46e-05	0.000679	CcSEcCtD
Indomethacin—Tachycardia—Epirubicin—sarcoma	8.43e-05	0.000677	CcSEcCtD
Indomethacin—Hyperhidrosis—Epirubicin—sarcoma	8.35e-05	0.000671	CcSEcCtD
Indomethacin—Chest pain—Doxorubicin—sarcoma	8.34e-05	0.000669	CcSEcCtD
Indomethacin—Anxiety—Doxorubicin—sarcoma	8.31e-05	0.000667	CcSEcCtD
Indomethacin—PTGS2—lymph node—sarcoma	8.25e-05	0.000817	CbGeAlD
Indomethacin—Discomfort—Doxorubicin—sarcoma	8.24e-05	0.000661	CcSEcCtD
Indomethacin—Anorexia—Epirubicin—sarcoma	8.24e-05	0.000661	CcSEcCtD
Indomethacin—ABCB1—bone marrow—sarcoma	8.23e-05	0.000816	CbGeAlD
Indomethacin—Hypotension—Epirubicin—sarcoma	8.07e-05	0.000648	CcSEcCtD
Indomethacin—Confusional state—Doxorubicin—sarcoma	8.06e-05	0.000647	CcSEcCtD
Indomethacin—Anaphylactic shock—Doxorubicin—sarcoma	7.99e-05	0.000642	CcSEcCtD
Indomethacin—Oedema—Doxorubicin—sarcoma	7.99e-05	0.000642	CcSEcCtD
Indomethacin—Shock—Doxorubicin—sarcoma	7.87e-05	0.000631	CcSEcCtD
Indomethacin—Thrombocytopenia—Doxorubicin—sarcoma	7.83e-05	0.000628	CcSEcCtD
Indomethacin—Insomnia—Epirubicin—sarcoma	7.81e-05	0.000627	CcSEcCtD
Indomethacin—Tachycardia—Doxorubicin—sarcoma	7.8e-05	0.000626	CcSEcCtD
Indomethacin—Paraesthesia—Epirubicin—sarcoma	7.76e-05	0.000623	CcSEcCtD
Indomethacin—Hyperhidrosis—Doxorubicin—sarcoma	7.73e-05	0.00062	CcSEcCtD
Indomethacin—Dyspnoea—Epirubicin—sarcoma	7.7e-05	0.000618	CcSEcCtD
Indomethacin—Somnolence—Epirubicin—sarcoma	7.68e-05	0.000617	CcSEcCtD
Indomethacin—Anorexia—Doxorubicin—sarcoma	7.62e-05	0.000612	CcSEcCtD
Indomethacin—Dyspepsia—Epirubicin—sarcoma	7.61e-05	0.000611	CcSEcCtD
Indomethacin—Decreased appetite—Epirubicin—sarcoma	7.51e-05	0.000603	CcSEcCtD
Indomethacin—Hypotension—Doxorubicin—sarcoma	7.47e-05	0.0006	CcSEcCtD
Indomethacin—Fatigue—Epirubicin—sarcoma	7.45e-05	0.000598	CcSEcCtD
Indomethacin—Pain—Epirubicin—sarcoma	7.39e-05	0.000593	CcSEcCtD
Indomethacin—Constipation—Epirubicin—sarcoma	7.39e-05	0.000593	CcSEcCtD
Indomethacin—Insomnia—Doxorubicin—sarcoma	7.23e-05	0.00058	CcSEcCtD
Indomethacin—Paraesthesia—Doxorubicin—sarcoma	7.18e-05	0.000576	CcSEcCtD
Indomethacin—Dyspnoea—Doxorubicin—sarcoma	7.13e-05	0.000572	CcSEcCtD
Indomethacin—Feeling abnormal—Epirubicin—sarcoma	7.12e-05	0.000572	CcSEcCtD
Indomethacin—Somnolence—Doxorubicin—sarcoma	7.11e-05	0.000571	CcSEcCtD
Indomethacin—Gastrointestinal pain—Epirubicin—sarcoma	7.07e-05	0.000567	CcSEcCtD
Indomethacin—Dyspepsia—Doxorubicin—sarcoma	7.04e-05	0.000565	CcSEcCtD
Indomethacin—ABCB1—testis—sarcoma	7.04e-05	0.000697	CbGeAlD
Indomethacin—Decreased appetite—Doxorubicin—sarcoma	6.95e-05	0.000558	CcSEcCtD
Indomethacin—Fatigue—Doxorubicin—sarcoma	6.89e-05	0.000553	CcSEcCtD
Indomethacin—Urticaria—Epirubicin—sarcoma	6.86e-05	0.000551	CcSEcCtD
Indomethacin—Pain—Doxorubicin—sarcoma	6.84e-05	0.000549	CcSEcCtD
Indomethacin—Constipation—Doxorubicin—sarcoma	6.84e-05	0.000549	CcSEcCtD
Indomethacin—Body temperature increased—Epirubicin—sarcoma	6.83e-05	0.000548	CcSEcCtD
Indomethacin—Abdominal pain—Epirubicin—sarcoma	6.83e-05	0.000548	CcSEcCtD
Indomethacin—ABCB1—liver—sarcoma	6.65e-05	0.000659	CbGeAlD
Indomethacin—Feeling abnormal—Doxorubicin—sarcoma	6.59e-05	0.000529	CcSEcCtD
Indomethacin—Gastrointestinal pain—Doxorubicin—sarcoma	6.54e-05	0.000525	CcSEcCtD
Indomethacin—Hypersensitivity—Epirubicin—sarcoma	6.37e-05	0.000511	CcSEcCtD
Indomethacin—Urticaria—Doxorubicin—sarcoma	6.35e-05	0.00051	CcSEcCtD
Indomethacin—Body temperature increased—Doxorubicin—sarcoma	6.32e-05	0.000507	CcSEcCtD
Indomethacin—Abdominal pain—Doxorubicin—sarcoma	6.32e-05	0.000507	CcSEcCtD
Indomethacin—Asthenia—Epirubicin—sarcoma	6.2e-05	0.000498	CcSEcCtD
Indomethacin—Pruritus—Epirubicin—sarcoma	6.11e-05	0.000491	CcSEcCtD
Indomethacin—Diarrhoea—Epirubicin—sarcoma	5.91e-05	0.000475	CcSEcCtD
Indomethacin—Hypersensitivity—Doxorubicin—sarcoma	5.89e-05	0.000473	CcSEcCtD
Indomethacin—Asthenia—Doxorubicin—sarcoma	5.74e-05	0.00046	CcSEcCtD
Indomethacin—Dizziness—Epirubicin—sarcoma	5.71e-05	0.000459	CcSEcCtD
Indomethacin—Pruritus—Doxorubicin—sarcoma	5.66e-05	0.000454	CcSEcCtD
Indomethacin—Vomiting—Epirubicin—sarcoma	5.49e-05	0.000441	CcSEcCtD
Indomethacin—Diarrhoea—Doxorubicin—sarcoma	5.47e-05	0.000439	CcSEcCtD
Indomethacin—Rash—Epirubicin—sarcoma	5.45e-05	0.000437	CcSEcCtD
Indomethacin—Dermatitis—Epirubicin—sarcoma	5.44e-05	0.000437	CcSEcCtD
Indomethacin—Headache—Epirubicin—sarcoma	5.41e-05	0.000435	CcSEcCtD
Indomethacin—Dizziness—Doxorubicin—sarcoma	5.29e-05	0.000424	CcSEcCtD
Indomethacin—Nausea—Epirubicin—sarcoma	5.13e-05	0.000412	CcSEcCtD
Indomethacin—ABCB1—lymph node—sarcoma	5.1e-05	0.000506	CbGeAlD
Indomethacin—Vomiting—Doxorubicin—sarcoma	5.08e-05	0.000408	CcSEcCtD
Indomethacin—Rash—Doxorubicin—sarcoma	5.04e-05	0.000405	CcSEcCtD
Indomethacin—Dermatitis—Doxorubicin—sarcoma	5.04e-05	0.000404	CcSEcCtD
Indomethacin—Headache—Doxorubicin—sarcoma	5.01e-05	0.000402	CcSEcCtD
Indomethacin—Nausea—Doxorubicin—sarcoma	4.75e-05	0.000381	CcSEcCtD
Indomethacin—PTGS2—Spinal Cord Injury—CCND1—sarcoma	2.96e-05	0.000708	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—PLCG1—sarcoma	2.93e-05	0.000699	CbGpPWpGaD
Indomethacin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	2.92e-05	0.000696	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TLE1—sarcoma	2.91e-05	0.000695	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—KDR—sarcoma	2.91e-05	0.000694	CbGpPWpGaD
Indomethacin—PTGS2—C-MYB transcription factor network—KRAS—sarcoma	2.88e-05	0.000689	CbGpPWpGaD
Indomethacin—ABCC4—Platelet activation, signaling and aggregation—SRC—sarcoma	2.87e-05	0.000686	CbGpPWpGaD
Indomethacin—ALB—Platelet degranulation—VEGFA—sarcoma	2.85e-05	0.000681	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	2.8e-05	0.000668	CbGpPWpGaD
Indomethacin—ABCC4—Platelet activation, signaling and aggregation—VEGFA—sarcoma	2.8e-05	0.000668	CbGpPWpGaD
Indomethacin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	2.72e-05	0.000649	CbGpPWpGaD
Indomethacin—ABCC1—Disease—TLE1—sarcoma	2.71e-05	0.000648	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	2.69e-05	0.000642	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—KDR—sarcoma	2.68e-05	0.000641	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—KIT—sarcoma	2.68e-05	0.00064	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—NRAS—sarcoma	2.68e-05	0.00064	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFC—sarcoma	2.57e-05	0.000613	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CREB1—sarcoma	2.55e-05	0.000609	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—PLCG1—sarcoma	2.54e-05	0.000606	CbGpPWpGaD
Indomethacin—ABCB1—Allograft Rejection—VEGFA—sarcoma	2.52e-05	0.000603	CbGpPWpGaD
Indomethacin—ALB—Folate Metabolism—TP53—sarcoma	2.51e-05	0.000601	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—FLT1—sarcoma	2.49e-05	0.000595	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—FOXO1—sarcoma	2.48e-05	0.000592	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PDGFRB—sarcoma	2.47e-05	0.000591	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFC—sarcoma	2.46e-05	0.000587	CbGpPWpGaD
Indomethacin—PTGS2—C-MYB transcription factor network—HRAS—sarcoma	2.45e-05	0.000585	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NPM1—sarcoma	2.45e-05	0.000585	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PLCG1—sarcoma	2.45e-05	0.000584	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—EGFR—sarcoma	2.44e-05	0.000583	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—PDGFRA—sarcoma	2.44e-05	0.000582	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—MYC—sarcoma	2.38e-05	0.000568	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—CREB1—sarcoma	2.35e-05	0.000562	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CXCR4—sarcoma	2.35e-05	0.000561	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—CTNNB1—sarcoma	2.34e-05	0.00056	CbGpPWpGaD
Indomethacin—CXCL8—Cellular responses to stress—TP53—sarcoma	2.34e-05	0.000559	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—EGFR—sarcoma	2.33e-05	0.000555	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—ATF1—sarcoma	2.32e-05	0.000555	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	2.31e-05	0.000553	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—KRAS—sarcoma	2.3e-05	0.000551	CbGpPWpGaD
Indomethacin—PPARG—Circadian rythm related genes—TP53—sarcoma	2.29e-05	0.000548	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—ENO2—sarcoma	2.27e-05	0.000541	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—ENO2—sarcoma	2.27e-05	0.000541	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—HBA1—sarcoma	2.25e-05	0.000538	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—HBA1—sarcoma	2.25e-05	0.000538	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—MMP2—sarcoma	2.19e-05	0.000523	CbGpPWpGaD
Indomethacin—CXCL8—Metabolism of proteins—MMP2—sarcoma	2.15e-05	0.000512	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—ENO2—sarcoma	2.14e-05	0.000512	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—HBA1—sarcoma	2.13e-05	0.000509	CbGpPWpGaD
Indomethacin—ABCC1—Disease—ENO2—sarcoma	2.12e-05	0.000506	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—SRC—sarcoma	2.12e-05	0.000506	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—MDM2—sarcoma	2.11e-05	0.000504	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—VEGFA—sarcoma	2.06e-05	0.000493	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—NRAS—sarcoma	2.04e-05	0.000487	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—PLCG1—sarcoma	2.02e-05	0.000482	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	2.02e-05	0.000482	CbGpPWpGaD
Indomethacin—PPARA—Generic Transcription Pathway—MYC—sarcoma	2.02e-05	0.000482	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	2.01e-05	0.000481	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	2e-05	0.000477	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	1.98e-05	0.000474	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—ENO2—sarcoma	1.97e-05	0.000471	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—FLT1—sarcoma	1.96e-05	0.000469	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—HBA1—sarcoma	1.96e-05	0.000468	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—HRAS—sarcoma	1.96e-05	0.000468	CbGpPWpGaD
Indomethacin—PTGS2—Spinal Cord Injury—TP53—sarcoma	1.95e-05	0.000466	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PLCG1—sarcoma	1.93e-05	0.000461	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—PLCG1—sarcoma	1.92e-05	0.000459	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—PLCG1—sarcoma	1.92e-05	0.000459	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—KIT—sarcoma	1.89e-05	0.000451	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—IL2—sarcoma	1.88e-05	0.00045	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—EGFR—sarcoma	1.86e-05	0.000443	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CXCR4—sarcoma	1.85e-05	0.000443	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—ENO2—sarcoma	1.84e-05	0.00044	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—ENO2—sarcoma	1.84e-05	0.00044	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CCND1—sarcoma	1.84e-05	0.000439	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—JUN—sarcoma	1.83e-05	0.000438	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—ATF1—sarcoma	1.83e-05	0.000438	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—HBA1—sarcoma	1.83e-05	0.000437	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—HBA1—sarcoma	1.83e-05	0.000437	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IGF1R—sarcoma	1.82e-05	0.000436	CbGpPWpGaD
Indomethacin—PTGS2—Disease—TLE1—sarcoma	1.82e-05	0.000435	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—CTNNB1—sarcoma	1.82e-05	0.000435	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—PLCG1—sarcoma	1.82e-05	0.000434	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.8e-05	0.000431	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PLCG1—sarcoma	1.8e-05	0.00043	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—CREB1—sarcoma	1.8e-05	0.000429	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—ENO2—sarcoma	1.78e-05	0.000424	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—HBA1—sarcoma	1.76e-05	0.000421	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.76e-05	0.00042	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—KRAS—sarcoma	1.75e-05	0.000419	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—FOXO1—sarcoma	1.74e-05	0.000415	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PDGFRB—sarcoma	1.73e-05	0.000414	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CXCR4—sarcoma	1.73e-05	0.000413	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—PDGFRA—sarcoma	1.71e-05	0.000407	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—IL2—sarcoma	1.7e-05	0.000405	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—ENO2—sarcoma	1.69e-05	0.000403	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—CREB1—sarcoma	1.68e-05	0.000402	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—CTNNB1—sarcoma	1.68e-05	0.000401	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—HBA1—sarcoma	1.68e-05	0.0004	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—PLCG1—sarcoma	1.67e-05	0.0004	CbGpPWpGaD
Indomethacin—CXCL8—Metabolism of proteins—CTNNB1—sarcoma	1.64e-05	0.000393	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—SRC—sarcoma	1.64e-05	0.000393	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NPM1—sarcoma	1.64e-05	0.000392	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	1.64e-05	0.000392	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.62e-05	0.000386	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—VEGFA—sarcoma	1.6e-05	0.000383	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—NRAS—sarcoma	1.58e-05	0.000378	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.58e-05	0.000378	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—PLCG1—sarcoma	1.56e-05	0.000373	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—PLCG1—sarcoma	1.56e-05	0.000373	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—SRC—sarcoma	1.52e-05	0.000362	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—PLCG1—sarcoma	1.51e-05	0.00036	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—ENO2—sarcoma	1.5e-05	0.000359	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.49e-05	0.000357	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—HBA1—sarcoma	1.49e-05	0.000356	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—HRAS—sarcoma	1.49e-05	0.000356	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—IL2—sarcoma	1.49e-05	0.000356	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—MDM2—sarcoma	1.49e-05	0.000355	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—SRC—sarcoma	1.48e-05	0.000354	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—VEGFA—sarcoma	1.48e-05	0.000353	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—MYC—sarcoma	1.47e-05	0.000352	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—NRAS—sarcoma	1.46e-05	0.000349	CbGpPWpGaD
Indomethacin—PPARG—Generic Transcription Pathway—MYC—sarcoma	1.44e-05	0.000345	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—VEGFA—sarcoma	1.44e-05	0.000344	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—EGFR—sarcoma	1.44e-05	0.000344	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IGF1R—sarcoma	1.44e-05	0.000344	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KDR—sarcoma	1.44e-05	0.000343	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—PLCG1—sarcoma	1.43e-05	0.000342	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.43e-05	0.000341	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.43e-05	0.000341	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—NRAS—sarcoma	1.42e-05	0.00034	CbGpPWpGaD
Indomethacin—PTGS2—Disease—ENO2—sarcoma	1.42e-05	0.00034	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.42e-05	0.000338	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—FOXO1—sarcoma	1.37e-05	0.000327	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—IL2—sarcoma	1.37e-05	0.000327	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PDGFRB—sarcoma	1.37e-05	0.000326	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—KRAS—sarcoma	1.36e-05	0.000325	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—PDGFRA—sarcoma	1.35e-05	0.000321	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—EGFR—sarcoma	1.33e-05	0.000318	CbGpPWpGaD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.33e-05	0.000317	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KIT—sarcoma	1.32e-05	0.000316	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—SRC—sarcoma	1.3e-05	0.00031	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—CTNNB1—sarcoma	1.28e-05	0.000306	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.28e-05	0.000306	CbGpPWpGaD
Indomethacin—ABCC1—Disease—FOXO1—sarcoma	1.28e-05	0.000305	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PDGFRB—sarcoma	1.27e-05	0.000304	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—PLCG1—sarcoma	1.27e-05	0.000304	CbGpPWpGaD
Indomethacin—ALB—Platelet activation, signaling and aggregation—VEGFA—sarcoma	1.27e-05	0.000302	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CREB1—sarcoma	1.26e-05	0.000301	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—KRAS—sarcoma	1.26e-05	0.0003	CbGpPWpGaD
Indomethacin—ABCC1—Disease—PDGFRA—sarcoma	1.25e-05	0.0003	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.25e-05	0.000298	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—IL2—sarcoma	1.24e-05	0.000297	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—KRAS—sarcoma	1.23e-05	0.000293	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—TP53—sarcoma	1.21e-05	0.000289	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PLCG1—sarcoma	1.21e-05	0.000288	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—ENO2—sarcoma	1.19e-05	0.000285	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—HBA1—sarcoma	1.18e-05	0.000283	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—SRC—sarcoma	1.16e-05	0.000277	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CXCR4—sarcoma	1.16e-05	0.000277	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—HRAS—sarcoma	1.16e-05	0.000276	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.15e-05	0.000274	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KDR—sarcoma	1.13e-05	0.000271	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.12e-05	0.000268	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—NRAS—sarcoma	1.12e-05	0.000267	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—TP53—sarcoma	1.09e-05	0.00026	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—HRAS—sarcoma	1.07e-05	0.000255	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.06e-05	0.000253	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KIT—sarcoma	1.04e-05	0.000249	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—NRAS—sarcoma	1.04e-05	0.000249	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MDM2—sarcoma	1.04e-05	0.000249	CbGpPWpGaD
Indomethacin—ABCC4—Hemostasis—HRAS—sarcoma	1.04e-05	0.000249	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—MYC—sarcoma	1.04e-05	0.000248	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—EGFR—sarcoma	1.02e-05	0.000243	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—PLCG1—sarcoma	1.01e-05	0.000241	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CREB1—sarcoma	9.93e-06	0.000237	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KIT—sarcoma	9.72e-06	0.000232	CbGpPWpGaD
Indomethacin—PPARA—Gene Expression—MYC—sarcoma	9.7e-06	0.000232	CbGpPWpGaD
Indomethacin—ALB—Metabolism—ENO2—sarcoma	9.64e-06	0.00023	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—KRAS—sarcoma	9.6e-06	0.000229	CbGpPWpGaD
Indomethacin—ALB—Metabolism—HBA1—sarcoma	9.58e-06	0.000229	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—EGFR—sarcoma	9.5e-06	0.000227	CbGpPWpGaD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	9.41e-06	0.000225	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—IL2—sarcoma	9.31e-06	0.000222	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CREB1—sarcoma	9.26e-06	0.000221	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CCND1—sarcoma	9.07e-06	0.000217	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—JUN—sarcoma	9.05e-06	0.000216	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—CTNNB1—sarcoma	8.98e-06	0.000215	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—KRAS—sarcoma	8.98e-06	0.000214	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—ENO2—sarcoma	8.65e-06	0.000207	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HBA1—sarcoma	8.6e-06	0.000205	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FOXO1—sarcoma	8.56e-06	0.000205	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PDGFRB—sarcoma	8.55e-06	0.000204	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—ENO2—sarcoma	8.45e-06	0.000202	CbGpPWpGaD
Indomethacin—PTGS2—Disease—PDGFRA—sarcoma	8.42e-06	0.000201	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HBA1—sarcoma	8.39e-06	0.0002	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MDM2—sarcoma	8.22e-06	0.000196	CbGpPWpGaD
Indomethacin—ALB—Metabolism—PLCG1—sarcoma	8.18e-06	0.000195	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—HRAS—sarcoma	8.16e-06	0.000195	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—SRC—sarcoma	8.12e-06	0.000194	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—VEGFA—sarcoma	7.91e-06	0.000189	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—ENO2—sarcoma	7.89e-06	0.000188	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HBA1—sarcoma	7.84e-06	0.000187	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—NRAS—sarcoma	7.81e-06	0.000187	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—IL2—sarcoma	7.67e-06	0.000183	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MDM2—sarcoma	7.66e-06	0.000183	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—HRAS—sarcoma	7.63e-06	0.000182	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—PLCG1—sarcoma	7.34e-06	0.000175	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—IL2—sarcoma	7.34e-06	0.000175	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—MYC—sarcoma	7.28e-06	0.000174	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—PLCG1—sarcoma	7.17e-06	0.000171	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CCND1—sarcoma	7.16e-06	0.000171	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—JUN—sarcoma	7.14e-06	0.000171	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—EGFR—sarcoma	7.12e-06	0.00017	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—CTNNB1—sarcoma	7.09e-06	0.000169	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—MYC—sarcoma	6.95e-06	0.000166	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KRAS—sarcoma	6.72e-06	0.000161	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—SRC—sarcoma	6.7e-06	0.00016	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—PLCG1—sarcoma	6.69e-06	0.00016	CbGpPWpGaD
Indomethacin—ABCC1—Disease—CTNNB1—sarcoma	6.61e-06	0.000158	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KIT—sarcoma	6.53e-06	0.000156	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—VEGFA—sarcoma	6.52e-06	0.000156	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—NRAS—sarcoma	6.44e-06	0.000154	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—SRC—sarcoma	6.41e-06	0.000153	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—VEGFA—sarcoma	6.24e-06	0.000149	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CREB1—sarcoma	6.21e-06	0.000148	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—NRAS—sarcoma	6.16e-06	0.000147	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—TP53—sarcoma	5.98e-06	0.000143	CbGpPWpGaD
Indomethacin—ABCC1—Disease—SRC—sarcoma	5.97e-06	0.000143	CbGpPWpGaD
Indomethacin—ABCC1—Disease—NRAS—sarcoma	5.74e-06	0.000137	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—MYC—sarcoma	5.74e-06	0.000137	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—HRAS—sarcoma	5.72e-06	0.000137	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—EGFR—sarcoma	5.61e-06	0.000134	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—KRAS—sarcoma	5.54e-06	0.000132	CbGpPWpGaD
Indomethacin—ABCC1—Disease—MYC—sarcoma	5.35e-06	0.000128	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KRAS—sarcoma	5.3e-06	0.000127	CbGpPWpGaD
Indomethacin—ABCC1—Disease—EGFR—sarcoma	5.23e-06	0.000125	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MDM2—sarcoma	5.14e-06	0.000123	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KRAS—sarcoma	4.94e-06	0.000118	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—TP53—sarcoma	4.93e-06	0.000118	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—TP53—sarcoma	4.71e-06	0.000113	CbGpPWpGaD
Indomethacin—ALB—Hemostasis—HRAS—sarcoma	4.71e-06	0.000113	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—HRAS—sarcoma	4.51e-06	0.000108	CbGpPWpGaD
Indomethacin—PTGS2—Disease—CTNNB1—sarcoma	4.43e-06	0.000106	CbGpPWpGaD
Indomethacin—ABCC1—Disease—HRAS—sarcoma	4.2e-06	0.0001	CbGpPWpGaD
Indomethacin—PTGS2—Disease—SRC—sarcoma	4.01e-06	9.57e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—NRAS—sarcoma	3.86e-06	9.21e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—MYC—sarcoma	3.59e-06	8.58e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—EGFR—sarcoma	3.51e-06	8.39e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KRAS—sarcoma	3.32e-06	7.93e-05	CbGpPWpGaD
Indomethacin—PTGS2—Disease—HRAS—sarcoma	2.82e-06	6.74e-05	CbGpPWpGaD
